Clonmel Healthcare Ltd., Coripharma ehf., STADA Arzneimittel AG, Germany
PolandAll drugs from this manufacturer
-
This medicine is used in adult patients with Ph-positive chronic myeloid leukemia, who have newly diagnosed disease or for whom previous treatment has not been effective or has been inappropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 100 mg ATC: L01EA04
-
The medicine is intended for adult patients with Ph-positive chronic myeloid leukemia who have newly diagnosed disease or for whom previous treatment has not been effective.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 400 mg ATC: L01EA04
-
The medicine is intended for adult patients with chronic myeloid leukemia with the presence of the Philadelphia chromosome (Ph-positive type), who have newly diagnosed disease or for whom previous treatment has not been effective or appropriate.
Dosage form: tablets, film-coated
Active substance Dosage bosutinib 500 mg ATC: L01EA04